MedAvail Holdings, Inc. (NASDAQ: MDVL) Stock Competitors & Peer Comparison
See MDVL's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MDVL and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDVL | $1.80 | -43.22% | 2.9M | -0.05 | -$35.56 | N/A |
| RPRX | $57.97 | +2.11% | 25.7B | 11.04 | $5.25 | +1.58% |
| CORT | $114.23 | +3.12% | 12.3B | 326.37 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $91.03 | +0.90% | 8.1B | 650.21 | $0.14 | N/A |
| KNSA | $76.53 | +0.62% | 5.8B | 85.03 | $0.90 | N/A |
| TRLV | $9.08 | +3.77% | 1.5B | -21.50 | -$0.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $18.56 | +1.70% | 1.1B | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
MDVL vs RPRX Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, RPRX has a market cap of 25.7B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while RPRX trades at $57.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas RPRX's P/E ratio is 11.04. In terms of profitability, MDVL's ROE is -2.39%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, MDVL is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
MDVL vs CORT Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CORT has a market cap of 12.3B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CORT trades at $114.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CORT's P/E ratio is 326.37. In terms of profitability, MDVL's ROE is -2.39%, compared to CORT's ROE of +0.08%. Regarding short-term risk, MDVL is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
MDVL vs WBA Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas WBA's P/E ratio is -1.64. In terms of profitability, MDVL's ROE is -2.39%, compared to WBA's ROE of -0.42%. Regarding short-term risk, MDVL is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
MDVL vs LQDA Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, LQDA has a market cap of 8.1B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while LQDA trades at $91.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas LQDA's P/E ratio is 650.21. In terms of profitability, MDVL's ROE is -2.39%, compared to LQDA's ROE of +0.47%. Regarding short-term risk, MDVL is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
MDVL vs KNSA Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, KNSA has a market cap of 5.8B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while KNSA trades at $76.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas KNSA's P/E ratio is 85.03. In terms of profitability, MDVL's ROE is -2.39%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, MDVL is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check KNSA's competition here
Trulieve Cannabis Corp. (NYSE: TRLV)
MDVL vs TRLV Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, TRLV has a market cap of 1.5B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while TRLV trades at $9.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas TRLV's P/E ratio is -21.50. In terms of profitability, MDVL's ROE is -2.39%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, MDVL is more volatile compared to TRLV. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check TRLV's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
MDVL vs HROWL Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas HROWL's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to HROWL's ROE of -0.34%. Regarding short-term risk, MDVL is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
MDVL vs HROWM Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas HROWM's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to HROWM's ROE of -0.34%. Regarding short-term risk, MDVL is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
MDVL vs LTGO Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, LTGO has a market cap of 1.1B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while LTGO trades at $18.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas LTGO's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to LTGO's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to LTGO. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check LTGO's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
MDVL vs CUVL Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CUVL has a market cap of 339.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CUVL trades at $6.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CUVL's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to CUVL's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CUVL's competition here
LifeMD, Inc. (NASDAQ: LFMD)
MDVL vs LFMD Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, LFMD has a market cap of 175.1M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while LFMD trades at $3.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas LFMD's P/E ratio is -7.24. In terms of profitability, MDVL's ROE is -2.39%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, MDVL is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check LFMD's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
MDVL vs LFMDP Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, LFMDP has a market cap of 160.2M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while LFMDP trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas LFMDP's P/E ratio is -724.19. In terms of profitability, MDVL's ROE is -2.39%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, MDVL is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check LFMDP's competition here
Circle8 Group, Inc. (NASDAQ: CIRC)
MDVL vs CIRC Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CIRC has a market cap of 63M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CIRC trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CIRC's P/E ratio is -1.59. In terms of profitability, MDVL's ROE is -2.39%, compared to CIRC's ROE of +0.00%. Regarding short-term risk, MDVL is more volatile compared to CIRC. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CIRC's competition here
Rite Aid Corporation (NYSE: RAD)
MDVL vs RAD Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas RAD's P/E ratio is -0.05. In terms of profitability, MDVL's ROE is -2.39%, compared to RAD's ROE of +2.76%. Regarding short-term risk, MDVL is more volatile compared to RAD. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
MDVL vs GLTO Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas GLTO's P/E ratio is -1.78. In terms of profitability, MDVL's ROE is -2.39%, compared to GLTO's ROE of -1.22%. Regarding short-term risk, MDVL is more volatile compared to GLTO. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check GLTO's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
MDVL vs SCYX Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SCYX has a market cap of 32.4M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SCYX trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SCYX's P/E ratio is -1.51. In terms of profitability, MDVL's ROE is -2.39%, compared to SCYX's ROE of -0.57%. Regarding short-term risk, MDVL is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SCYX's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
MDVL vs NSRX Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, NSRX has a market cap of 29.4M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while NSRX trades at $3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas NSRX's P/E ratio is -4.74. In terms of profitability, MDVL's ROE is -2.39%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, MDVL is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check NSRX's competition here
Stablecoin Development Corp. (AMEX: SDEV)
MDVL vs SDEV Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SDEV has a market cap of 27.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SDEV trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SDEV's P/E ratio is -0.18. In terms of profitability, MDVL's ROE is -2.39%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, MDVL is more volatile compared to SDEV. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SDEV's competition here
Cerenome, Inc. (NASDAQ: CNSY)
MDVL vs CNSY Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CNSY has a market cap of 26.4M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CNSY trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CNSY's P/E ratio is -0.53. In terms of profitability, MDVL's ROE is -2.39%, compared to CNSY's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to CNSY. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CNSY's competition here
Biofrontera Inc. (NASDAQ: BFRI)
MDVL vs BFRI Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, BFRI has a market cap of 15.5M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while BFRI trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas BFRI's P/E ratio is -1.13. In terms of profitability, MDVL's ROE is -2.39%, compared to BFRI's ROE of -4.77%. Regarding short-term risk, MDVL is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check BFRI's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
MDVL vs CJJD Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CJJD's P/E ratio is -0.46. In terms of profitability, MDVL's ROE is -2.39%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, MDVL is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
MDVL vs SSY Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SSY's P/E ratio is -2.86. In terms of profitability, MDVL's ROE is -2.39%, compared to SSY's ROE of -0.09%. Regarding short-term risk, MDVL is more volatile compared to SSY. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
MDVL vs POM Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, POM has a market cap of 7.3M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while POM trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas POM's P/E ratio is -0.21. In terms of profitability, MDVL's ROE is -2.39%, compared to POM's ROE of +0.16%. Regarding short-term risk, MDVL is more volatile compared to POM. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check POM's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
MDVL vs PAVS Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, PAVS has a market cap of 6.4M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while PAVS trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas PAVS's P/E ratio is -0.08. In terms of profitability, MDVL's ROE is -2.39%, compared to PAVS's ROE of -0.27%. Regarding short-term risk, MDVL is more volatile compared to PAVS. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check PAVS's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
MDVL vs HKPD Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, HKPD has a market cap of 4.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while HKPD trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas HKPD's P/E ratio is -6.99. In terms of profitability, MDVL's ROE is -2.39%, compared to HKPD's ROE of -0.14%. Regarding short-term risk, MDVL is more volatile compared to HKPD. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check HKPD's competition here
AIxCrypto Holdings, Inc. (NASDAQ: AIXC)
MDVL vs AIXC Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, AIXC has a market cap of 4.1M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while AIXC trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas AIXC's P/E ratio is -0.09. In terms of profitability, MDVL's ROE is -2.39%, compared to AIXC's ROE of -0.94%. Regarding short-term risk, MDVL is more volatile compared to AIXC. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check AIXC's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
MDVL vs ATNFW Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas ATNFW's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to ATNFW's ROE of -2.41%. Regarding short-term risk, MDVL is more volatile compared to ATNFW. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
MDVL vs BGMSP Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, MDVL's ROE is -2.39%, compared to BGMSP's ROE of -0.51%. Regarding short-term risk, MDVL is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check BGMSP's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
MDVL vs BGMS Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, BGMS has a market cap of 2M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while BGMS trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas BGMS's P/E ratio is -0.25. In terms of profitability, MDVL's ROE is -2.39%, compared to BGMS's ROE of -0.51%. Regarding short-term risk, MDVL is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check BGMS's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
MDVL vs AZNH Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas AZNH's P/E ratio is 38.35. In terms of profitability, MDVL's ROE is -2.39%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, MDVL is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
MDVL vs LFLYW Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, MDVL's ROE is -2.39%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, MDVL is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check LFLYW's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFMW)
MDVL vs SBFMW Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SBFMW has a market cap of 175.2K. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SBFMW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SBFMW's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to SBFMW's ROE of -0.26%. Regarding short-term risk, MDVL is less volatile compared to SBFMW. This indicates lower risk in terms of short-term price fluctuations for MDVL.Check SBFMW's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
MDVL vs ESRX Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas ESRX's P/E ratio is 10.69. In terms of profitability, MDVL's ROE is -2.39%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, MDVL is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check ESRX's competition here
POZEN Inc. (NASDAQ: POZN)
MDVL vs POZN Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, POZN has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas POZN's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to POZN's ROE of +0.61%. Regarding short-term risk, MDVL is more volatile compared to POZN. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check POZN's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
MDVL vs OREX Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, OREX has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas OREX's P/E ratio is -0.14. In terms of profitability, MDVL's ROE is -2.39%, compared to OREX's ROE of -0.54%. Regarding short-term risk, MDVL is more volatile compared to OREX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check OREX's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
MDVL vs IPXL Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas IPXL's P/E ratio is -10.11. In terms of profitability, MDVL's ROE is -2.39%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, MDVL is more volatile compared to IPXL. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check IPXL's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
MDVL vs CPD Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CPD has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CPD's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to CPD's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CPD's competition here
Shire plc (NASDAQ: SHPG)
MDVL vs SHPG Comparison August 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SHPG's P/E ratio is 11.35. In terms of profitability, MDVL's ROE is -2.39%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, MDVL is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SHPG's competition here